Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipesh Uprety

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Cancers|May 13, 2023
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid TumorsGary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Lung Cancer in NepalRamila Shilpakar, Bishnu Dutta Paudel, Rajeev Sharma, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigensJonas Fischer, Katherine H Shutta, Chen Chen, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
JTO Clinical and Research Reports|September 9, 2022
Characterization of <i>MET</i> Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome SequencingSo Yeon Kim, Jun Yin, Stephen Bohlman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow's Guide in the ClinicJarushka Naidoo, Abesh Niroula, Dipesh Uprety, et al.
Cancer Research Communications|May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant CancersHusain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancers|May 13, 2023
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid TumorsGary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
Real-World Biomarker-Associated Therapy in Metastatic Carcinoma of Unknown Primary: Prevalence, Impact, and OutcomesDipesh Uprety, Kieran Sweeney, Lubina Arjyal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2021
Lung Cancer in NepalRamila Shilpakar, Bishnu Dutta Paudel, Rajeev Sharma, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigensJonas Fischer, Katherine H Shutta, Chen Chen, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
JTO Clinical and Research Reports|September 9, 2022
Characterization of <i>MET</i> Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome SequencingSo Yeon Kim, Jun Yin, Stephen Bohlman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow's Guide in the ClinicJarushka Naidoo, Abesh Niroula, Dipesh Uprety, et al.
Cancer Research Communications|May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant CancersHusain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Clinical Lung Cancer|November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Pageof 7